Screen Reader Mode Icon
We are assessing interest in qualitative Nucleic Acid Testing (NAT) for Malaria using a test kit registered on the ARTG as a Class 4 in vitro diagnostic (IVD). This test will be performed under TGA license and intended for both donor screening and diagnostic purposes.

Your feedback will help us understand sector needs and guide the potential development of a business case.

Question Title

* 1. Contact Details

Question Title

* 3. Organisation

Question Title

* 4. Would qualitative NAT for malaria be relevant to your current or future testing needs (e.g., donor screening or diagnostics)?

Question Title

* 5. What setting(s) would be most relevant for Malaria NAT testing in your context? (Select all that apply)

Question Title

* 6. Would you be interested in receiving updates or contributing to a potential business case for Malaria NAT testing?

Question Title

* 7. Is there anything else you'd like to add or suggest regarding Malaria NAT testing?

0 of 7 answered
 

T